|
| | Diagnosis | Sex | Age | BMI | Notes |
|
| Healthy | Adenoma | F | 48 | 29 | — |
| Cholangiocellular carcinoma | F | 50 | 20 | — |
|
| Multimorbidity | Klatskin tumor | M | 80 | 31 | Hypercholesterolemia |
| Colorectal liver metastasis | M | 72 | 23 | Coronary heart disease |
| Cholangiocellular carcinoma | M | 74 | 29 | Diabetes, hypertension, and in situ split |
| Gall bladder carcinoma | F | 57 | 28 | Portal vein embolisation, hypertension, and cholestasis |
| Cholangiocellular carcinoma | F | 75 | 24 | Hypercholesterolemia |
| Cholangiocellular carcinoma | M | 61 | 31 | Hypertension, hypercholesterolemia |
| Hemangioma | F | 43 | 28.4 | Diabetes |
| Cholangiocellular carcinoma | M | 47 | 23 | Terminal renal failure, hypercholesterolemia |
|
| Chronic inflammation | Klatskin tumor | M | 72 | 24 | Chronic inflammation, diabetes, and hypertension |
|
| Portal vein embolisation | Colorectal liver metastasis | F | 60 | — | Portal vein embolisation |
| Colorectal liver metastasis | M | 57 | 28 | Portal vein embolisation, chemotherapy |
|
| Cholestasis | Cholangiocellular carcinoma | F | 72 | 22 | Cholestasis |
| Cholangiocellular carcinoma | F | 77 | 22 | Cholestasis |
|
| Chemotherapy | Colorectal liver metastasis | F | 71 | — | Chemotherapy |
|
| Hepatic steatosis | Hepatocellular carcinoma | M | 75 | — | Resection area, steatohepatitis |
| Adenoma | F | 32 | — | Diabetes, steatohepatitis |
|
| Resection area | Hemangioma | M | 47 | 27 | Resection area |
| Cholangiocellular carcinoma | M | 62 | 25 | Resection area, chemotherapy |
|
| Donor A | Focal nodular hyperplasia | F | 19 | 22 | — |
|
| Donor B | Colorectal liver metastasis | M | 50 | 23 | Diabetes, smoker |
|
| Donor C | Klatskin tumor | M | 52 | 25 | Diabetes, portal vein embolisation |
|
